Cargando…
Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444495/ https://www.ncbi.nlm.nih.gov/pubmed/36137935 http://dx.doi.org/10.1016/j.dld.2022.08.038 |
_version_ | 1784783237384503296 |
---|---|
author | Festa, Stefano De Biasio, Fabiola Aratari, Annalisa Papi, Claudio |
author_facet | Festa, Stefano De Biasio, Fabiola Aratari, Annalisa Papi, Claudio |
author_sort | Festa, Stefano |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9444495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94444952022-09-06 Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection Festa, Stefano De Biasio, Fabiola Aratari, Annalisa Papi, Claudio Dig Liver Dis Correspondence Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022-11 2022-09-06 /pmc/articles/PMC9444495/ /pubmed/36137935 http://dx.doi.org/10.1016/j.dld.2022.08.038 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Festa, Stefano De Biasio, Fabiola Aratari, Annalisa Papi, Claudio Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection |
title | Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection |
title_full | Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection |
title_fullStr | Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection |
title_full_unstemmed | Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection |
title_short | Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection |
title_sort | intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant sars-cov-2 infection |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444495/ https://www.ncbi.nlm.nih.gov/pubmed/36137935 http://dx.doi.org/10.1016/j.dld.2022.08.038 |
work_keys_str_mv | AT festastefano intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection AT debiasiofabiola intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection AT aratariannalisa intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection AT papiclaudio intentionaltreatmentwithtofacitinibinapatientwithsevererefractoryulcerativecolitisandconcomitantsarscov2infection |